GIOVANNI SCHIFITTO, MD
Psychiatric at Elmwood Ave, Rochester, NY
License number
New York 215806
Category
Psychiatric
Type
Vascular Neurology
Address
Address
601 Elmwood Ave, Rochester, NY 14642
Phone
(585) 275-4423
(585) 473-4678 (Fax)
(585) 473-4678 (Fax)
Personal information
See more information about GIOVANNI SCHIFITTO at radaris.comName
Address
Phone
2 Evandale Rd, Rochester, NY 14618
2 Evandale Rd, Rochester, NY 14618
Organization information
See more information about GIOVANNI SCHIFITTO at bizstanding.comGiovanni Schifitto MD
601 Elmwood Ave, Rochester, NY 14642
Industry:
Neurologist
Phone:
(585) 275-3052 (Phone)
Giovanni Schifitto
Professional information
Dr. Giovanni Schifitto, Rochester NY - MD (Doctor of Medicine)
Specialties:
Neuropsychiatry (Neurology)
Address:
University-Rochester Medical
601 Elmwood Ave, Rochester 14642
(585) 275-0558 (Phone)
601 Elmwood Ave, Rochester 14642
(585) 275-0558 (Phone)
Certifications:
Neurology, 1995
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University-Rochester Medical
601 Elmwood Ave, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
601 Elmwood Ave, Rochester 14642
Strong Memorial Hospital
601 Elmwood Ave, Rochester 14642
Education:
Residency Hospital
Mt Sinai School Of Med
Strong Mem Hsp University Rochester
Mt Sinai School Of Med
Strong Mem Hsp University Rochester
Treatment Of Neuroads Using Inhibitors Of Glycogen Synthase Kinase (Gsk)-3
US Patent:
2009008, Mar 26, 2009
Filed:
Dec 19, 2006
Appl. No.:
12/158896
Inventors:
Harris A. Gelbard - Pittsford NY, US
Sanjay B. Maggirwar - Rochester NY, US
Stephen Dewhurst - Rochester NY, US
Giovanni Schifitto - Rochester NY, US
Sanjay B. Maggirwar - Rochester NY, US
Stephen Dewhurst - Rochester NY, US
Giovanni Schifitto - Rochester NY, US
International Classification:
A61K 33/00, A61K 31/55, A61K 31/19
US Classification:
424722, 514215, 514557
Abstract:
Provided is a method of treating or preventing neurological disease in a subject in need of such treatment or prevention, comprising administering to the subject a therapeutically effective dose of a GSK-3 inhibitor.